Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions - PubMed (original) (raw)
. 1997 Aug 1;57(15):3305-13.
Affiliations
- PMID: 9242465
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions
T Nakamura et al. Cancer Res. 1997.
Abstract
Invasive and metastatic potentials of several types of carcinoma cells are regulated through interactions with host stromal cells, e.g., tumor-stromal interactions. Because hepatocyte growth factor (HGF), a ligand for the c-Met proto-oncogene product, is a mesenchymal- or stromal-derived factor that induces mitogenic, motogenic, and morphogenic responses, we examined the mechanisms involved in tumor-stromal interactions in vitro. The c-Met/HGF receptor was expressed in A431 human epidermoid carcinoma cells, A549 human non-small cell lung cancer cells, HuCC-T1 human cholangiocellular carcinoma cells, and SBC-3 human small cell lung carcinoma cells. HGF stimulated cell growth, scattering, and invasion of these cells. Although these cells did not produce biologically significant levels of HGF, these cells did secrete soluble factors that potently stimulated HGF production in human skin fibroblasts. These carcinoma cell-derived HGF inducers proved to be interleukin-1 (IL-1) in A431 cells, IL-1 plus basic fibroblast growth factor (bFGF) in A549 and HuCC-T1 cells, and bFGF plus platelet-derived growth factor in SBC-3 cells. When these carcinoma cells were cocultured with fibroblasts, HGF levels in the coculture system were much higher than the levels in fibroblasts alone, without cocultured carcinoma cells. Together with the increase in HGF levels, the number of invasive cells increased, but in vitro invasion of carcinoma cells in the coculture system was strongly inhibited by anti-HGF antibodies. Thus, there are mutual interactions between carcinoma cells and fibroblasts: IL-1, bFGF, and platelet-derived growth factor derived from tumor cells play a role in inducing HGF expression in stromal fibroblasts, whereas fibroblast-derived HGF, in turn, leads to invasive growth in carcinoma cells. The mutual interactions, as mediated by HGF and HGF inducers, may play a significant role in the occurrence of invasion and metastasis of carcinoma cells.
Similar articles
- Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N, Matsumoto K, Nakamura T. Matsumoto-Taniura N, et al. Br J Cancer. 1999 Sep;81(2):194-202. doi: 10.1038/sj.bjc.6690677. Br J Cancer. 1999. PMID: 10496342 Free PMC article. - Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T. Hasina R, et al. Br J Cancer. 1999 Aug;80(11):1708-17. doi: 10.1038/sj.bjc.6690587. Br J Cancer. 1999. PMID: 10468286 Free PMC article. - Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J. Neaud V, et al. Hepatology. 1997 Dec;26(6):1458-66. doi: 10.1053/jhep.1997.v26.pm0009397985. Hepatology. 1997. PMID: 9397985 - Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K, Nakamura T, Sakai K, Nakamura T. Matsumoto K, et al. Proteomics. 2008 Aug;8(16):3360-70. doi: 10.1002/pmic.200800156. Proteomics. 2008. PMID: 18646008 Review. - Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W. Weidner KM, et al. EXS. 1993;65:311-28. EXS. 1993. PMID: 8380739 Review.
Cited by
- Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N, Matsumoto K, Nakamura T. Matsumoto-Taniura N, et al. Br J Cancer. 1999 Sep;81(2):194-202. doi: 10.1038/sj.bjc.6690677. Br J Cancer. 1999. PMID: 10496342 Free PMC article. - Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.
Watson GA, Zhang X, Stang MT, Levy RM, Queiroz de Oliveira PE, Gooding WE, Christensen JG, Hughes SJ. Watson GA, et al. Neoplasia. 2006 Nov;8(11):949-55. doi: 10.1593/neo.06499. Neoplasia. 2006. PMID: 17132227 Free PMC article. - Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
Zeng L, Cao J, Zhang X. Zeng L, et al. World J Gastroenterol. 2005 Oct 21;11(39):6202-7. doi: 10.3748/wjg.v11.i39.6202. World J Gastroenterol. 2005. PMID: 16273651 Free PMC article. - Induction of c-met proto-oncogene expression at the metastatic site.
Imai J, Watanabe M, Sasaki M, Yamaguchi R, Tateyama S, Sugano S. Imai J, et al. Clin Exp Metastasis. 1999 Jul;17(5):457-62. doi: 10.1023/a:1006659515706. Clin Exp Metastasis. 1999. PMID: 10651314 - Role of cancer cell-stroma interaction in invasive growth of cancer cells.
Kataoka H, Tanaka H, Nagaike K, Uchiyama S, Itoh H. Kataoka H, et al. Hum Cell. 2003 Mar;16(1):1-14. doi: 10.1111/j.1749-0774.2003.tb00123.x. Hum Cell. 2003. PMID: 12971620 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous